Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement

Background. The area under the curve- (AUC-) guided vancomycin dosing is the best strategy for individualized therapy in critical illnesses. Since AUC can be calculated directly using drug clearance (CLvan), any parameter estimating CLvan will be able to achieve the goal of 24-hour AUC (AUC24 h). Th...

Full description

Bibliographic Details
Main Authors: Bita Shahrami, Farhad Najmeddin, Saeideh Ghaffari, Atabak Najafi, Mohammad Reza Rouini, Mojtaba Mojtahedzadeh
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Critical Care Research and Practice
Online Access:http://dx.doi.org/10.1155/2020/8831138
id doaj-dd4bb82493d0446aa08a3695d35a025f
record_format Article
spelling doaj-dd4bb82493d0446aa08a3695d35a025f2021-01-04T00:00:23ZengHindawi LimitedCritical Care Research and Practice2090-13132020-01-01202010.1155/2020/8831138Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance MeasurementBita Shahrami0Farhad Najmeddin1Saeideh Ghaffari2Atabak Najafi3Mohammad Reza Rouini4Mojtaba Mojtahedzadeh5Department of Clinical PharmacyDepartment of Clinical PharmacySchool of PharmacyDepartment of Anesthesiology and Critical CareDepartment of PharmaceuticsDepartment of Clinical PharmacyBackground. The area under the curve- (AUC-) guided vancomycin dosing is the best strategy for individualized therapy in critical illnesses. Since AUC can be calculated directly using drug clearance (CLvan), any parameter estimating CLvan will be able to achieve the goal of 24-hour AUC (AUC24 h). The present study was aimed to determine CLvan based on 6-hour urine creatinine clearance measurement in critically ill patients with normal renal function. Method. 23 adult critically ill patients with an estimated glomerular filtration rate (eGFR) ≥60 mL/min who received vancomycin infusion were enrolled in this pilot study. Vancomycin pharmacokinetic parameters were determined for each patient using serum concentration data and a one-compartment model provided by MONOLIX software using stochastic approximation expectation-maximization (SAEM) algorithm. Correlation of CLvan with the measured creatinine clearance in 6-hour urine collection (CL6 h) and estimated creatinine clearance by the Cockcroft–Gault formula (CLCG) was investigated. Results. Data analysis revealed that CL6 h had a stronger correlation with CLvan rather than CLCG (r = 0.823 vs. 0.594; p<0.001 vs. 0.003). The relationship between CLvan and CL6 h was utilized to develop the following equation for estimating CLvan: CLvan (mL/min) = ─137.4 + CL6 h (mL/min) + 2.5 IBW (kg) (R2 = 0.826, p<0.001). Regarding the described model, the following equation can be used to calculate the empirical dose of vancomycin for achieving the therapeutic goals in critically ill patients without renal impairment: total daily dose of vancomycin (mg) = (─137.4CL6-h (mL/min) + 2.5 IBW (kg)) × 0.06 AUC24 h (mg.hr/L). Conclusion. For AUC estimation, CLvan can be obtained by collecting urine in a 6-hour period with good approximation in critically ill patients with normal renal function.http://dx.doi.org/10.1155/2020/8831138
collection DOAJ
language English
format Article
sources DOAJ
author Bita Shahrami
Farhad Najmeddin
Saeideh Ghaffari
Atabak Najafi
Mohammad Reza Rouini
Mojtaba Mojtahedzadeh
spellingShingle Bita Shahrami
Farhad Najmeddin
Saeideh Ghaffari
Atabak Najafi
Mohammad Reza Rouini
Mojtaba Mojtahedzadeh
Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
Critical Care Research and Practice
author_facet Bita Shahrami
Farhad Najmeddin
Saeideh Ghaffari
Atabak Najafi
Mohammad Reza Rouini
Mojtaba Mojtahedzadeh
author_sort Bita Shahrami
title Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
title_short Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
title_full Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
title_fullStr Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
title_full_unstemmed Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement
title_sort area under the curve-based dosing of vancomycin in critically ill patients using 6-hour urine creatinine clearance measurement
publisher Hindawi Limited
series Critical Care Research and Practice
issn 2090-1313
publishDate 2020-01-01
description Background. The area under the curve- (AUC-) guided vancomycin dosing is the best strategy for individualized therapy in critical illnesses. Since AUC can be calculated directly using drug clearance (CLvan), any parameter estimating CLvan will be able to achieve the goal of 24-hour AUC (AUC24 h). The present study was aimed to determine CLvan based on 6-hour urine creatinine clearance measurement in critically ill patients with normal renal function. Method. 23 adult critically ill patients with an estimated glomerular filtration rate (eGFR) ≥60 mL/min who received vancomycin infusion were enrolled in this pilot study. Vancomycin pharmacokinetic parameters were determined for each patient using serum concentration data and a one-compartment model provided by MONOLIX software using stochastic approximation expectation-maximization (SAEM) algorithm. Correlation of CLvan with the measured creatinine clearance in 6-hour urine collection (CL6 h) and estimated creatinine clearance by the Cockcroft–Gault formula (CLCG) was investigated. Results. Data analysis revealed that CL6 h had a stronger correlation with CLvan rather than CLCG (r = 0.823 vs. 0.594; p<0.001 vs. 0.003). The relationship between CLvan and CL6 h was utilized to develop the following equation for estimating CLvan: CLvan (mL/min) = ─137.4 + CL6 h (mL/min) + 2.5 IBW (kg) (R2 = 0.826, p<0.001). Regarding the described model, the following equation can be used to calculate the empirical dose of vancomycin for achieving the therapeutic goals in critically ill patients without renal impairment: total daily dose of vancomycin (mg) = (─137.4CL6-h (mL/min) + 2.5 IBW (kg)) × 0.06 AUC24 h (mg.hr/L). Conclusion. For AUC estimation, CLvan can be obtained by collecting urine in a 6-hour period with good approximation in critically ill patients with normal renal function.
url http://dx.doi.org/10.1155/2020/8831138
work_keys_str_mv AT bitashahrami areaunderthecurvebaseddosingofvancomycinincriticallyillpatientsusing6hoururinecreatinineclearancemeasurement
AT farhadnajmeddin areaunderthecurvebaseddosingofvancomycinincriticallyillpatientsusing6hoururinecreatinineclearancemeasurement
AT saeidehghaffari areaunderthecurvebaseddosingofvancomycinincriticallyillpatientsusing6hoururinecreatinineclearancemeasurement
AT atabaknajafi areaunderthecurvebaseddosingofvancomycinincriticallyillpatientsusing6hoururinecreatinineclearancemeasurement
AT mohammadrezarouini areaunderthecurvebaseddosingofvancomycinincriticallyillpatientsusing6hoururinecreatinineclearancemeasurement
AT mojtabamojtahedzadeh areaunderthecurvebaseddosingofvancomycinincriticallyillpatientsusing6hoururinecreatinineclearancemeasurement
_version_ 1714959886483193856